Christophe Marguet

2.9k total citations · 1 hit paper
52 papers, 1.4k citations indexed

About

Christophe Marguet is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Christophe Marguet has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 16 papers in Physiology and 14 papers in Epidemiology. Recurrent topics in Christophe Marguet's work include Asthma and respiratory diseases (16 papers), Cystic Fibrosis Research Advances (13 papers) and Pediatric health and respiratory diseases (12 papers). Christophe Marguet is often cited by papers focused on Asthma and respiratory diseases (16 papers), Cystic Fibrosis Research Advances (13 papers) and Pediatric health and respiratory diseases (12 papers). Christophe Marguet collaborates with scholars based in France, Brazil and United Kingdom. Christophe Marguet's co-authors include Paulo Augusto Moreira Camargos, L. Couderc, A. Deschildre, Daniel Siret, J. de Blic, Astrid Vabret, Jacques Brouard, Laurent Mély, J.‐C. Dubus and Jennifer Da Silva and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Christophe Marguet

49 papers receiving 1.4k citations

Hit Papers

Rapid Improvement after Starting Elexacaftor–Tezacaftor–I... 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christophe Marguet France 20 920 414 365 171 164 52 1.4k
Malcolm Brodlie United Kingdom 28 1.2k 1.3× 323 0.8× 331 0.9× 304 1.8× 128 0.8× 94 1.9k
Laurent Mély France 23 957 1.0× 387 0.9× 127 0.3× 157 0.9× 116 0.7× 68 1.5k
Paraskevi Xepapadaki Greece 22 485 0.5× 653 1.6× 380 1.0× 125 0.7× 99 0.6× 76 1.4k
Peter Greally Ireland 25 1.0k 1.1× 242 0.6× 164 0.4× 192 1.1× 164 1.0× 66 1.5k
Olli‐Pekka Alho Finland 23 542 0.6× 186 0.4× 320 0.9× 316 1.8× 95 0.6× 61 1.5k
Philippe Reix France 22 1.2k 1.3× 243 0.6× 191 0.5× 243 1.4× 133 0.8× 124 1.7k
C. Thumerelle France 15 361 0.4× 233 0.6× 186 0.5× 276 1.6× 54 0.3× 62 923
Marijke Proesmans Belgium 31 1.7k 1.9× 231 0.6× 547 1.5× 365 2.1× 139 0.8× 125 2.4k
Deni̇z Doğru Türkiye 21 985 1.1× 200 0.5× 280 0.8× 530 3.1× 184 1.1× 186 1.7k
J. Pukander Finland 25 562 0.6× 251 0.6× 622 1.7× 367 2.1× 54 0.3× 69 1.7k

Countries citing papers authored by Christophe Marguet

Since Specialization
Citations

This map shows the geographic impact of Christophe Marguet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Marguet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Marguet more than expected).

Fields of papers citing papers by Christophe Marguet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Marguet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Marguet. The network helps show where Christophe Marguet may publish in the future.

Co-authorship network of co-authors of Christophe Marguet

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Marguet. A scholar is included among the top collaborators of Christophe Marguet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Marguet. Christophe Marguet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leoz, Marie, et al.. (2025). Impact of RNA extraction on respiratory microbiome analysis using third-generation sequencing. BMC Genomics. 26(1). 908–908. 1 indexed citations
2.
Letierce, Alexia, Eric Deneuville, Nathalie Stremler, et al.. (2025). Beyond the Lung. Impact of Elexacaftor/Tezacaftor/Ivacaftor on Sinonasal Disease in Children With Cystic Fibrosis. International Forum of Allergy & Rhinology. 15(7). 715–723.
3.
Marguet, Christophe, et al.. (2024). Three-year outcome of a very young severe uncontrolled preschool wheezers cohort, a real-life study. Respiratory Medicine. 235. 107875–107875. 1 indexed citations
4.
Couderc, L., et al.. (2023). The combination of Ara h 2‐sIgE and basophil activation test could be an alternative to oral food challenge in cases of suspected peanut allergy. Pediatric Allergy and Immunology. 34(8). e14007–e14007. 1 indexed citations
5.
Schuers, Matthieu, Christophe Marguet, Xavier Humbert, et al.. (2023). Positive and negative viral associations in patients with acute respiratory tract infections in primary care: the ECOVIR study. Frontiers in Public Health. 11. 1269805–1269805. 6 indexed citations
6.
Delmas, Marie-Christine, Christophe Marguet, & Bénédicte Leynaert. (2023). Time trends in the prevalence of asthma in French schoolchildren. Respiratory Medicine and Research. 83. 101003–101003. 2 indexed citations
7.
Schuers, Matthieu, Sandrine Corbet, Xavier Humbert, et al.. (2022). The Design and Implementation of the ECOVIR Project: A Primary Health Care Surveillance System to Strengthen Co-Detection of Respiratory Viruses in Normandy. Methods and Protocols. 5(6). 98–98. 3 indexed citations
8.
Burgel, Pierre‐Régis, I. Durieu, R. Chiron, et al.. (2021). Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 204(1). 64–73. 148 indexed citations breakdown →
9.
Gajdos, Vincent, François Angoulvant, Pierre‐Olivier Vidalain, et al.. (2021). High Frequency of Viral Co-Detections in Acute Bronchiolitis. Viruses. 13(6). 990–990. 16 indexed citations
10.
Combret, Yann, Fairuz Boujibar, Clément Médrinal, et al.. (2021). Measurement properties of the one-minute sit-to-stand test in children and adolescents with cystic fibrosis: A multicenter randomized cross-over trial. PLoS ONE. 16(2). e0246781–e0246781. 17 indexed citations
11.
Burgel, Pierre‐Régis, À. Munck, I. Durieu, et al.. (2019). Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 201(2). 188–197. 92 indexed citations
12.
Mirkovic, Bojan, et al.. (2017). A case-control association study of 12 candidate genes and attempted suicide in French adolescents. International Journal of Adolescent Medicine and Health. 32(1). 8 indexed citations
13.
Hallit, Souheil, J. de Blic, Christophe Marguet, et al.. (2017). Respiratory and allergic symptoms in early life: The ELFE cohort. PA4146–PA4146. 1 indexed citations
14.
Deschildre, A., Christophe Marguet, Julia Salleron, et al.. (2013). Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey. European Respiratory Journal. 42(5). 1224–1233. 136 indexed citations
15.
Marguet, Christophe, Loïc Favennec, Olivier Matray, et al.. (2012). Clinical and microbiological efficacy of micafungin on Geosmithia argillacea infection in a cystic fibrosis patient. Medical Mycology Case Reports. 1(1). 79–81. 14 indexed citations
16.
Camargos, Paulo Augusto Moreira, et al.. (2011). Bronquiolite obliterante pós-infecciosa em crianças. SHILAP Revista de lepidopterología. 18 indexed citations
17.
Camargos, Paulo Augusto Moreira, et al.. (2011). Post-infectious bronchiolitis obliterans in children. Jornal de Pediatria. 0(0). 187–98. 27 indexed citations
18.
Marguet, Christophe, et al.. (2007). Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias. The Brazilian Journal of Infectious Diseases. 11(5). 507–514. 50 indexed citations
19.
Flamant, Cyril, Alexandra Henrion‐Caude, Jacques Brouard, et al.. (2004). Glutathione-S-transferase M1, M3, P1 and T1 polymorphisms and severity of lung disease in children with cystic fibrosis. Pharmacogenetics. 14(5). 295–301. 36 indexed citations
20.
Marguet, Christophe, Taraneh Dean, & John O. Warner. (2000). Soluble Intercellular Adhesion Molecule-1 (sICAM-1) and Interferon-Gamma in Bronchoalveolar Lavage Fluid from Children with Airway Diseases. American Journal of Respiratory and Critical Care Medicine. 162(3). 1016–1022. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026